<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04295434</url>
  </required_header>
  <id_info>
    <org_study_id>BP-CON-ESH</org_study_id>
    <nct_id>NCT04295434</nct_id>
  </id_info>
  <brief_title>Blood Pressure Control in ESH Excellence Centres</brief_title>
  <acronym>BP-CON</acronym>
  <official_title>Study of the European Society of Hypertension on Blood Pressure Control in ESH Excellence Centres</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Centre Zagreb</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Society of Hypertension</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Hospital Centre Zagreb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients
      seen consecutively by the ESH Excellence Centres. Blood pressure will be measured as usually
      done in the office, but care will be adopted to make measurements highly standardized in all
      Centres. The primary goals will be to determine the global, regional and country rates of
      hypertension control in Europe. Other goals will be to identify global and regional factors
      associated with blood pressure control in different European regions. The results obtained in
      the BP-CON-ESH project will be used to refine treatment strategies for improvement of blood
      pressure control and will serve as a basis for assessing future changes and trends in Europe.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The most important task of the European Society of Hypertension is to improve blood pressure
      treatment and increase blood pressure control, thus decreasing cardiovascular risk, premature
      cardiovascular and renal morbidity and mortality, with in addition a reduction of health-care
      costs. More than a decade ago, the European Society of Hypertension established a network of
      Excellence Centres. Those centres are leading institutions for the diagnosis and treatment of
      hypertension and thus are front runners of good clinical practice in hypertension management
      in their countries. An important task of the Excellence Centres is also to be active in
      research, particularly in projects conducted by the European Society of Hypertension. The
      ongoing BP-CON-ESH project on the rate of blood pressure control in hypertensive patients
      addresses the most elementary,but at the same timethe most important aspect in hypertension
      management, because the observed low rates of blood pressure control is the reason why
      hypertension is still today the leading cause of death worldwide.

      In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients
      seen consecutively by the ESH Excellence Centres. Blood pressure will be measured as usually
      done in the office, but care will be adopted to make measurements highly standardized in all
      Centres.

      The primary goals will be to determine the global, regional and country rates of hypertension
      control in Europe. Other goals will be to identify global and regional factors associated
      with blood pressure control in different European regions. It is well known that the overall
      control of hypertension in Europe is still insufficient. However, the problem is not the same
      across Europe. Differences in healthcare systems exist among European countries, and in some
      countries government healthcare system only partially reimburse costs of antihypertensive
      therapy. There are also differences in gross national product, educational levels, salt
      consumption, prevalence of obesity and other aspects. These could cause dissimilarities in
      hypertension prevalence, achieved blood pressure control and cardiovascular mortality among
      European regions.

      The results obtained in the BP-CON-ESH project will be used to refine treatment strategies
      for improvement of blood pressure control and will serve as a basis for assessing future
      changes and trends in Europe.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure control</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Difference in blood pressure values between ESH Excellence Centres</description>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Lifestyle Risk Reduction</condition>
  <condition>White Coat Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with hypertension that are under supervision of excellence centres participating
        in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

        Exclusion Criteria:

          -  Pregnancy and breastfeeding

          -  Terminal malignancy, reduced life expectancy (&lt;6 months)

          -  Amputated limb

          -  Dementia

          -  Patients living in a nursing home

          -  Unsigned informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bojan Jelaković, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Hospital Centre Zagreb</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bojan Jelaković, MD, PhD</last_name>
    <phone>00385959030751</phone>
    <email>jelakovicbojan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Branimir Krtalić, MD</last_name>
    <phone>00385923314348</phone>
    <email>bkrtalic@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center of Preventive Cardiology, Yerevan</name>
      <address>
        <city>Yerevan</city>
        <zip>0014</zip>
        <country>Armenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Parounak Zelveian, MD</last_name>
      <email>zelveian@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Wels-Grieskirchen</name>
      <address>
        <city>Wels</city>
        <zip>4600</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Weber, MD</last_name>
      <email>thomas.weber3@liwest.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Van de Borne, MD, Prof</last_name>
      <email>philippe.van.de.borne@erasme.ulb.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marie Krzesinski, MD, Prof</last_name>
      <email>jm.krzesinski@chu.ulg.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ambroise Paré University Hospital</name>
      <address>
        <city>Mons</city>
        <zip>7000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Delmotte, MD</last_name>
      <email>Philippe.Delmotte@hap.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital &quot;St. Anna&quot;</name>
      <address>
        <city>Sofia</city>
        <zip>1750</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dimitar Raev, Prof</last_name>
      <email>draevbg56@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University hospital centre Zagreb</name>
      <address>
        <city>Zagreb</city>
        <state>Grad Zagreb</state>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bojan Jelaković, MD, PhD</last_name>
      <phone>00385959030751</phone>
      <email>jelakovicbojan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charles University Medical School and University Hospital</name>
      <address>
        <city>Plzen</city>
        <zip>30599</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Filipovský, MD, Prof</last_name>
      <email>filipovsky@fnplzen.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Hypertension, Charles University, Prague</name>
      <address>
        <city>Praha</city>
        <zip>12808</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiri Widimsky Jr., MD, Prof</last_name>
      <email>jwidi@lf1.cuni.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute for Clinical and Experimental Medicine (IKEM) and Thomayer Hospital, Prague</name>
      <address>
        <city>Praha</city>
        <zip>14059</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renata Cifkova, MD, Prof</last_name>
      <email>renata.cifkova@ftn.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tallinn Hypertension Excellence Centre</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margus Viigimaa, Prof, MD</last_name>
      <email>margus.viigimaa@regionaalhaigla.ee</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertension Center Berlin Charité</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reinhold Kreutz, Prof, MD</last_name>
      <email>reinhold.kreutz@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertoniezentrum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53123</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rainer Düsing, MD, Prof</last_name>
      <email>dusing@outlook.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hanover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Beger, MD</last_name>
      <email>Beger.Christian@mh-hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätskliniken des Saarlandes</name>
      <address>
        <city>Homburg</city>
        <zip>D-66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Böhm, MD</last_name>
      <email>michael.boehm@uks.eu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertension Center Munich</name>
      <address>
        <city>Munich</city>
        <zip>80333</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Middeke, MD, Prof</last_name>
      <email>martin.middeke@gmx.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertension and Cardiovascular Prevention Clinic, 3rd Department of Medicine, Evangelismos Hospital</name>
      <address>
        <city>Athens</city>
        <zip>10676</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Andreadis, MD</last_name>
      <email>andreadise@ath.forthnet.gr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertension Clinic, University Hospital Laiko</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dimitris P Papadopoulos, MD</last_name>
      <email>jimpapdoc@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Athens, Hippokration Hospital</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Costas Tsioufis, Prof, MD</last_name>
      <email>ktsioufis@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertension Clinic, Department of Cardiology, KAT General Hospital</name>
      <address>
        <city>Athens</city>
        <zip>14561</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charalampos Grassos, MD</last_name>
      <email>harigrass@yahoo.gr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertension Clinic, Cardiology Department, Asklepeion Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Athansios Manolis, Prof, MD</last_name>
      <email>ajmanol@otenet.gr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Heraklion</name>
      <address>
        <city>Heraklion</city>
        <zip>71110</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioannis Papadakis, MD</last_name>
      <email>papadakisja@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Maria Marketou, MD</last_name>
      <email>maryemarke@yahoo.gr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hypertension Center, Department of Nephrology, University Hospital of Ioannina</name>
      <address>
        <city>Ioánnina</city>
        <zip>45500</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rigas Kalaitzidis, MD</last_name>
      <email>rigaska@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertension Outpatient Clinic, 1st Propedeutic Dept. of Internal Medicine, AHEPA Hospital</name>
      <address>
        <city>Thessaloníki</city>
        <zip>54636</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Apostolos Hatzitolios, MD</last_name>
      <email>axatzito@med.auth.gr</email>
    </contact>
    <contact_backup>
      <last_name>Pantelis Zebekakis, Prof, MD</last_name>
      <email>pzebeka@med.auth.gr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hypertension Center, Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki</name>
      <address>
        <city>Thessaloníki</city>
        <zip>54642</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pantelis Sarafidis, MD</last_name>
      <email>psarafidis11@yahoo.gr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aristotle University of Thessaloniki, Papageorgiou General Hospital</name>
      <address>
        <city>Thessaloníki</city>
        <zip>56403</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stella Douma, Prof, MD</last_name>
      <email>sdouma@med.auth.gr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Assuta Ashdod University Hospital</name>
      <address>
        <city>Ashdod</city>
        <zip>7747629</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adi Leiba, Prof, MD</last_name>
      <email>drleiba@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre of Prevention and Treatment of Arterial Hypertension and Cardiovascular Risk Factors</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Enrico Agabiti Rosei, Prof, MD</last_name>
      <email>enrico.agabitirosei@unibs.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>S. Luca Hospital, Istituto Auxologico Italiano</name>
      <address>
        <city>Milan</city>
        <zip>20149</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianfranco Parati, Prof, MD</last_name>
      <email>gianfranco.parati@unimib.it</email>
    </contact>
    <contact_backup>
      <last_name>Martino Pengo, MD</last_name>
      <email>m.pengo@auxologico.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ospedale Niguarda, Dip. De Gasperis e Università di Milano Bicocca</name>
      <address>
        <city>Milan</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Giannattasio, Prof, MD</last_name>
      <email>cristina.giannattasio@unimib.it</email>
    </contact>
    <contact_backup>
      <last_name>Alessandro Maloberti, MD</last_name>
      <email>alessandro.maloberti@ospedaleniguarda.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Napoli Hypertension Excellence Centre, Federico II Clinic Research Center for Hypertension and Related Conditions</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raffaele Izzo, Prof, MD</last_name>
      <email>rafizzo@unina.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Excellence Centre of Hypertension, Department of Medical Sciences, University of Torino</name>
      <address>
        <city>Torino</city>
        <zip>10124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Franco Veglio, Prof</last_name>
      <email>franco.veglio@unito.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>American University Center, Hypertension/Vascular Medicine Division (Associated Centre)</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Abdel Berbari, MD</last_name>
      <email>ab01@aub.edu.lb</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaunas Hypertension Excellence Centre</name>
      <address>
        <city>Kaunas</city>
        <zip>47101</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rimvydas Slapikas, Prof, MD</last_name>
      <email>rimvydas.slapikas@kmuk.lt</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Maastricht</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter De Leeuw, Prof, MD</last_name>
      <email>p.deleeuw@maastrichtuniversity.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radboud University of Nijmegen Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacob Deinum, MD</last_name>
      <email>j.deinum@aig.umcn.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine, Hypertension and Vascular Diseases, Warsaw Medical University</name>
      <address>
        <city>Warsaw</city>
        <zip>02-091</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zbigniew Gaciong, MD</last_name>
      <email>zgaciong@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar do Alto Ave, Minho University</name>
      <address>
        <city>Guimarães</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Cotter, Prof, MD</last_name>
      <email>jorgecotter@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Cardiology and Internal Medicine, Emergency Clinical Hospital of Bucharest</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Dorobantu, MD</last_name>
      <email>maria.dorobantu@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre for Hypertension of the Clinical Centre of Serbia</name>
      <address>
        <city>Belgrad</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vesna Stojanov, MD</last_name>
      <email>stojanovves@eunet.rs</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hipertensión Clinic, Internal Medicine, Hospital Clinico, University of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cristina Sierra, MD, PhD</last_name>
      <email>csierra@clinic.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hypertension Clinic, Nephrology Department, Reina Sofia University Hospital</name>
      <address>
        <city>Córdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rafael Santamaría, MD</last_name>
      <email>rsantamariao@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Danderyd University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>182 57</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Kahan, Prof, MD</last_name>
      <email>thomas.kahan@sll.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Scientific Center &quot;The M.D. Strazhesko Institute of Cardiology&quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>02000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yuri Sirenko, MD, PhD</last_name>
      <email>sirenkoyu@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Bartholomew's Royal London School of Medicine &amp; Dentistry</name>
      <address>
        <city>London</city>
        <zip>E1 2AD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melvin Lobo, MD PhD</last_name>
      <email>m.d.lobo@qmul.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Pearl-Rose Clinic (Hypertension &amp; Cardiovascular Risk), Hammersmith Hospital,</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Neil Chapman, MD</last_name>
      <email>neil.chapman1@nhs.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Armenia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>Estonia</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Lebanon</country>
    <country>Lithuania</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.eshonline.org/communities/excellence-centres/blood-pressure-control-in-esh-excellence-centres-bp-con-esh/</url>
    <description>ESH website with relevant informations on BP CON study</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2020</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Centre Zagreb</investigator_affiliation>
    <investigator_full_name>Prof. Bojan Jelaković</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Blood pressure</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Control</keyword>
  <keyword>European</keyword>
  <keyword>Excellence centres</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>White Coat Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

